Clinical Care of Bone Health in Patients on the Immune Tolerance Induction’s Protocols With an Immunosuppressive Agent for Inhibitor Eradication in Hemophilia

Clinical Care of Bone Health in Patients on the Immune Tolerance Induction’s Protocols With an Immunosuppressive Agent for Inhibitor Eradication in Hemophilia

Nowadays, the development of factor VIII and IX inhibitors in patients with hemophilia is considered as the most challenging in the treatment of hemophilia. Immune tolerance induction (ITI) therapy is an approach for eradication of inhibitors. Some ITI protocols are routinely in use for the eradicat...

Full description

Bibliographic Details
Main Authors:	Zahra Rezaieyazdi MD, Hassan Mansouritorghabeh PhD
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-06-01
Series:	Clinical and Applied Thrombosis/Hemostasis
Online Access:	https://doi.org/10.1177/1076029620913951

Similar Items

The Current Status of Bone Marrow Transplantation in Treatment of Patients with Hemophilia
by: Hassan Mansouritorghabeh, et al.
Published: (2014-05-01)

Clinical and Laboratory Approaches to Hemophilia A
by: Hassan Mansouritorghabeh
Published: (2015-05-01)

Low‐dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors
by: Zekun Li, et al.
Published: (2021-07-01)

Immune tolerance induction in a severe hemophilia B child with low titer inhibitors
by: Asia Almulla, et al.
Published: (2022-01-01)

Role of Regulatory Cells in Immune Tolerance Induction in Hemophilia A
by: Sarah J. Schep, et al.
Published: (2021-05-01)

Experience of induction of immune tolerance in patients with inhibitor form of hemophilia A in the presence of negative prognostic factors
by: N. I. Zozulya
Published: (2008-12-01)

Female case with misdiagnosis of hemophilia A who underwent total knee arthroplasty: A case report
by: Alireza Bari, et al.
Published: (2022-03-01)

Application of peripherally inserted central catheter in immune tolerance induction treatment of children with hemophilia A and accompanying inhibitors in China
by: Chunli Wang, et al.
Published: (2023-12-01)

The Treatment of Acquired Hemophilia with Combination Therapy of Immunosuppressives and Immunoadsorption
by: Aynur Uğur Bilgin, et al.
Published: (2014-05-01)

Low‐dose immune tolerance induction in children with severe hemophilia A with high‐titer inhibitors: Type of factor 8 mutation and outcomes
by: Jie Sun, et al.
Published: (2022-10-01)

Low‐dose immune tolerance induction for children with hemophilia A with poor‐risk high‐titer inhibitors: A pilot study in China
by: Zekun Li, et al.
Published: (2019-10-01)

Alterations of T cell receptor Vβ repertoire of CD8 T lymphocytes in immune tolerance induction in two hemophilia A patients with inhibitors
by: Sakurai Yoshihiko, et al.
Published: (2011-01-01)

Sensing Methods of Immunosuppressant Drugs: Calcineurin Inhibitors and Purine Synthesis Inhibitor Agents
by: Zahra Golsanamlou, et al.
Published: (2021-12-01)

The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophilia
by: Yosuke Inukai, et al.
Published: (2022-01-01)

Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor
by: Takeshi Matsumoto MD, PhD, et al.
Published: (2019-01-01)

CD4 monoclonal antibody pairs for immunosuppression and tolerance induction.
by: Qin, S, et al.
Published: (1987)

Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes
by: Ricardo Mesquita Camelo, et al.
Published: (2023-01-01)

Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran
by: Rasekh HR, et al.
Published: (2011-11-01)

Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A
by: Benjamin J. Samelson-Jones, et al.
Published: (2020-04-01)

Predictors of the outcome of immune tolerance induction in patients with haemophilia A and inhibitors: The Brazilian Immune Tolerance (BrazIT) Study protocol.
by: Ricardo Mesquita Camelo, et al.
Published: (2021-01-01)

Parvovirus 4 in Individuals with Severe Hemophilia A and Matched Control Group
by: Sanaz Asiyabi, et al.
Published: (2021-07-01)

Emicizumab in tolerized patients with hemophilia A with inhibitors: A single‐institution pediatric cohort assessing inhibitor status
by: Glaivy Batsuli, et al.
Published: (2021-02-01)

The effect of the applied induction immunosuppressive therapy protocol on the allografted kidney condition
by: V. A. Goryaynov, et al.
Published: (2017-03-01)

Escape or Fight: Inhibitors in Hemophilia A
by: Simone Merlin, et al.
Published: (2020-03-01)

Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A
by: Alexandra Sherman, et al.
Published: (2017-11-01)

Men, Masculinities, and Hemophilia
by: Laszlo Kalmar RN, MSN, et al.
Published: (2016-11-01)

The immunosuppressive agent mizoribine monophosphate is an inhibitor of the human RNA capping enzyme.
by: Frédéric Picard-Jean, et al.
Published: (2013-01-01)

The impact of inhibitors on the quality of life in patients with hemophilia
by: Sezaneh Haghpanah, et al.
Published: (2023-07-01)

Development of inhibitors in hemophilia A: An illustrated review
by: Letícia Lemos Jardim, et al.
Published: (2020-07-01)

Costs of the management of hemophilia A with inhibitors in Spain
by: Santiago Bonanad, et al.
Published: (2021-04-01)

IMPLEMENTATION OF MICROELIMINATION STRATEGY IN ERADICATION OF CHRONIC HEPATITIS C INFECTION IN PATIENTS WITH HEMOPHILIA IN THE NORTHERN REGION OF SERBIA
by: Maja Ružić, et al.
Published: (2021-08-01)

Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors
by: Saba HI, et al.
Published: (2012-05-01)

Oral tolerance induction protocols for treatment: an overview
by: Burks Wesley
Published: (2011-08-01)

Comparative analysis of induction immunosuppressive therapy protocols in renal transplant recipients (retrospective review)
by: Sh. R. Galeev, et al.
Published: (2020-07-01)

Manual therapy in the treatment of patients with hemophilia B and inhibitor
by: Rubén Cuesta-Barriuso, et al.
Published: (2018-01-01)

Physical and psychosocial challenges in adult hemophilia patients with inhibitors
by: duTreil S
Published: (2014-07-01)

Immunosuppressive Effect of Polycyclic Aromatic Hydrocarbons by Induction of Apoptosis of pre-B Lymphocytes of Bone Marrow
by: Jakub Novosad, et al.
Published: (2002-01-01)

Hemostatic System (Fibrinogen Level, D-Dimer, and FDP) in Severe and Non-Severe Patients With COVID-19: A Systematic Review and Meta-Analysis
by: Rostami Mehrdad MSc, et al.
Published: (2021-12-01)

Mammalian target of rapamycin inhibitors: A paradigm shift in current immunosuppression protocols
by: Indranil Ghosh, et al.
Published: (2016-01-01)

Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
by: Martina Guthoff, et al.
Published: (2020-05-01)